← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Business Officer Pamela Esposito sold $28K of Replimune Group, Inc.

Sold$28,000
$20.00Price
1,400Shares
−1%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Fri, Aug 11. Filed Tue, Aug 15, 4:30 PM ET, after the close. Not investment advice.